Alsouqi, A., Huang, Y., Rike, L., Dweik, L., Hinton, S., Moran, M., Reid, M., Hoffman, C., Grantier, C., Lucas, M., Bajwa, A., Bhat, S., Grever, M., Rogers, K., Shah, H., Woyach, J., Kittai, A. (2025). A phase II multi-institutional Study evaluating the safety and efficacy of the combination of lisocabtagene maraleucel and zanubrutinib in patients with richter transformation. Blood. https://doi.org/10.1182/blood-2025-1953